Income Statement VERE THER

Stocks

VERV

US92539P1012

Market Closed - NYSE Other stock markets 16:00:00 2025-07-24 EDT			5-day change	1st Jan Change
11.13 ^USD	+0.27%		-.--%	-

25-07-27	Verve Therapeutics, Inc.(NasdaqGS:VERV) dropped from S&P Biotechnology Select Industry Index	CI
25-07-27	Verve Therapeutics, Inc.(NasdaqGS:VERV) dropped from S&P Global BMI Index	CI

76af6f4ce786835d4a.MUWDg-265HtnYTEfFiNSf4-4rnDJudJIo-izhgUYF7k.AhLm84veqQI1JUNUSUYjL6Lt-BWbjZYNy6bVy11NSPMHLtnljumAElcJXg

Published financial data: VERE THER

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	-	-	1.94M	11.76M	32.33M
Total Revenues	-	-	1.94M	11.76M	32.33M
Cost of Goods Sold, Total	-	-	130M	185M	204M
Gross Profit	-	-	-128M	-173M	-172M
Selling General & Admin Expenses, Total	5.26M	18.86M	37.53M	49.94M	56.64M
R&D Expenses	35.37M	68.2M	-	-	-
Other Operating Expenses, Total	40.63M	87.07M	37.53M	49.94M	56.64M
Operating Income	-40.63M	-87.07M	-166M	-223M	-229M
Interest And Investment Income	162K	142K	6.87M	23.17M	28.76M
Net Interest Expenses	162K	142K	6.87M	23.17M	28.76M
Other Non Operating Income (Expenses)	-5.24M	-33.39M	1.49M	165K	1.54M
EBT, Excl. Unusual Items	-45.7M	-120M	-157M	-200M	-198M
EBT, Incl. Unusual Items	-45.7M	-120M	-157M	-200M	-198M
Income Tax Expense	-	-	53K	275K	349K
Earnings From Continuing Operations	-45.7M	-120M	-157M	-200M	-199M
Net Income to Company	-45.7M	-120M	-157M	-200M	-199M
Net Income - (IS)	-45.7M	-120M	-157M	-200M	-199M
Net Income to Common Incl Extra Items	-45.7M	-120M	-157M	-200M	-199M
Net Income to Common Excl. Extra Items	-45.7M	-120M	-157M	-200M	-199M
Per Share Items
Net EPS - Basic	-20.31	-4.48	-2.91	-3.12	-2.35
Basic EPS - Continuing Operations	-20.31	-4.48	-2.91	-3.12	-2.35
Basic Weighted Average Shares Outstanding	2.25M	26.87M	54.02M	64.18M	84.72M
Net EPS - Diluted	-20.31	-4.48	-2.91	-3.12	-2.35
Diluted EPS - Continuing Operations	-20.31	-4.48	-2.91	-3.12	-2.35
Diluted Weighted Average Shares Outstanding	2.25M	26.87M	54.02M	64.18M	84.72M
Normalized Basic EPS	-12.7	-2.8	-1.82	-1.95	-1.46
Normalized Diluted EPS	-12.7	-2.8	-1.82	-1.95	-1.46
Supplemental Items
EBITDA	-39.3M	-85.53M	-163M	-218M	-222M
EBITA	-40.63M	-87.07M	-166M	-223M	-229M
EBIT	-40.63M	-87.07M	-166M	-223M	-229M
EBITDAR	-38M	-80.58M	-155M	-200M	-201M
Effective Tax Rate - (Ratio)	-	-	-0.03	-0.14	-0.18
Current Domestic Taxes	-	-	53K	275K	349K
Total Current Taxes	-	-	53K	275K	349K
Normalized Net Income	-28.56M	-75.2M	-98.33M	-125M	-124M
Supplemental Operating Expense Items
General and Administrative Expenses	5.26M	18.86M	37.53M	49.94M	56.64M
Research And Development Expense From Footnotes	35.37M	68.2M	130M	185M	204M
Net Rental Expense, Total	1.3M	4.95M	8.24M	18.05M	20.44M
Stock-Based Comp., COGS (Total)	-	-	12.49M	19.12M	22.85M
Stock-Based Comp., R&D Exp. (Total)	494K	3.83M	-	-	-
Stock-Based Comp., G&A Exp. (Total)	356K	3.24M	9.99M	15.99M	20.4M
Total Stock-Based Compensation	850K	7.07M	22.48M	35.12M	43.26M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	8.99M	64.33M	115M	206M	173M
Short Term Investments	63.12M	296M	439M	418M	352M
Total Cash And Short Term Investments	72.11M	360M	555M	624M	524M
Accounts Receivable, Total	-	-	1.01M	5.9M	3.26M
Total Receivables	-	-	1.01M	5.9M	3.26M
Prepaid Expenses	1.85M	6.69M	7.34M	8.1M	15.22M
Total Current Assets	73.97M	367M	563M	638M	543M
Gross Property Plant And Equipment	4.78M	11.4M	116M	118M	114M
Accumulated Depreciation	-798K	-2.33M	-4.99M	-10.39M	-17.11M
Net Property Plant And Equipment	3.98M	9.06M	111M	108M	96.73M
Other Long-Term Assets, Total	463K	7.93M	5.41M	6.94M	7.92M
Total Assets	78.41M	384M	679M	753M	647M
Liabilities
Accounts Payable, Total	36K	7.08M	2.42M	6.64M	4.52M
Accrued Expenses, Total	7.11M	12.99M	20.46M	19.68M	24.34M
Current Portion of Leases	-	1.96M	11.9M	10.19M	10.44M
Unearned Revenue Current, Total	-	-	-	-	3.6M
Other Current Liabilities	173K	-	310K	500K	-
Total Current Liabilities	7.32M	22.02M	35.1M	37.01M	42.91M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	-	70.01M	64.72M	59.54M
Unearned Revenue Non Current	-	-	20.01M	48.56M	50.26M
Other Non Current Liabilities	9.85M	4.75M	3.17M	2.91M	1.28M
Total Liabilities	17.16M	26.77M	128M	153M	154M
Preferred Stock Convertible	125M	-	-	-	-
Total Preferred Equity	125M	-	-	-	-
Common Stock, Total	24K	49K	62K	82K	89K
Additional Paid In Capital	2.6M	544M	896M	1.14B	1.24B
Retained Earnings	-66.54M	-187M	-344M	-544M	-743M
Comprehensive Income and Other	8K	-228K	-694K	272K	428K
Total Common Equity	-63.91M	357M	551M	600M	493M
Total Equity	61.25M	357M	551M	600M	493M
Total Liabilities And Equity	78.41M	384M	679M	753M	647M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.18M	48.58M	61.83M	83.62M	88.8M
ECS Total Common Shares Outstanding	2.18M	48.51M	61.73M	81.97M	88.76M
Book Value / Share	-29.28	7.37	8.92	7.31	5.56
Tangible Book Value	-63.91M	357M	551M	600M	493M
Tangible Book Value Per Share	-29.28	7.37	8.92	7.31	5.56
Total Debt	0	1.96M	81.92M	74.91M	69.98M
Net Debt	-72.11M	-358M	-473M	-549M	-454M
Debt Equivalent Oper. Leases	10.4M	39.58M	65.96M	144M	164M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	4.52M	9.29M	23.5M	32.17M	34.98M
Full Time Employees	-	113	204	255	274

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-45.7M	-120M	-157M	-200M	-199M
Depreciation & Amortization - CF	1.33M	1.54M	2.8M	5.46M	6.75M
Depreciation & Amortization, Total	1.33M	1.54M	2.8M	5.46M	6.75M
(Gain) Loss on Sale of Investments - (CF)	380K	1.51M	-1.03M	-14.38M	-12.4M
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	850K	7.07M	22.48M	35.12M	43.26M
Other Operating Activities, Total	5.24M	35.23M	2.42M	6.63M	5.68M
Change In Accounts Receivable	-	-	-1.01M	-5.89M	2.64M
Change In Accounts Payable	-1.9M	6.83M	-5.22M	3.91M	-1.83M
Change in Unearned Revenues	-	-	20.01M	28.54M	5.31M
Change in Other Net Operating Assets	4.54M	-9.74M	-5.41M	-8.86M	-8.38M
Cash from Operations	-35.26M	-77.88M	-122M	-150M	-158M
Capital Expenditure	-3.42M	-4.36M	-13.23M	-9.28M	-3.74M
Investment in Marketable and Equity Securities, Total	-47.7M	-235M	-143M	36.97M	78.61M
Cash from Investing	-51.13M	-239M	-156M	27.69M	74.88M
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Issuance of Common Stock	11K	287M	330M	213M	49.26M
Issuance of Preferred Stock	92.73M	93.76M	-	-	-
Other Financing Activities, Total	-112K	-3.63M	-783K	-458K	-66K
Cash from Financing	92.63M	377M	329M	213M	49.2M
Net Change in Cash	6.24M	60.11M	50.67M	90.72M	-33.62M
Supplemental Items
Levered Free Cash Flow	-24.46M	-42.25M	-90.05M	-110M	-95.46M
Unlevered Free Cash Flow	-24.46M	-42.25M	-90.05M	-110M	-95.46M
Change In Net Working Capital	-2.18M	-7.92M	-1.46M	2.02M	-1.18M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-50.75	-23.53	-19.48	-19.48	-20.41
Return on Total Capital	-66.17	-25.88	-20.87	-21.34	-23.09
Return On Equity %	-136.07	-57.48	-34.66	-34.78	-36.36
Return on Common Equity	109.52	-82	-34.66	-34.78	-36.36
Margin Analysis
Gross Profit Margin %	-	-	-6.6K	-1.47K	-532.03
SG&A Margin	-	-	1.93K	424.7	175.2
EBITDA Margin %	-	-	-8.39K	-1.85K	-686.34
EBITA Margin %	-	-	-8.54K	-1.9K	-707.22
EBIT Margin %	-	-	-8.54K	-1.9K	-707.22
Income From Continuing Operations Margin %	-	-	-8.11K	-1.7K	-614.59
Net Income Margin %	-	-	-8.11K	-1.7K	-614.59
Net Avail. For Common Margin %	-	-	-8.11K	-1.7K	-614.59
Normalized Net Income Margin	-	-	-5.07K	-1.06K	-383.44
Levered Free Cash Flow Margin	-	-	-4.64K	-937.14	-295.24
Unlevered Free Cash Flow Margin	-	-	-4.64K	-937.14	-295.24
Asset Turnover
Asset Turnover	-	-	0	0.02	0.05
Fixed Assets Turnover	-	-	0.03	0.11	0.32
Receivables Turnover (Average Receivables)	-	-	-	3.4	7.07
Short Term Liquidity
Current Ratio	10.11	16.67	16.05	17.24	12.65
Quick Ratio	9.86	16.37	15.84	17.02	12.29
Operating Cash Flow to Current Liabilities	-4.82	-3.54	-3.49	-4.04	-3.68
Days Sales Outstanding (Average Receivables)	-	-	-	107.24	51.8
Average Days Payable Outstanding	-	-	13.33	8.94	9.99
Long Term Solvency
Total Debt/Equity	-	0.55	14.87	12.49	14.18
Total Debt / Total Capital	-	0.54	12.94	11.11	12.42
LT Debt/Equity	-	-	12.71	10.79	12.07
Long-Term Debt / Total Capital	-	-	11.06	9.6	10.57
Total Liabilities / Total Assets	21.89	6.97	18.89	20.35	23.79
Total Debt / EBITDA	-	-0.02	-0.53	-0.38	-0.35
Net Debt / EBITDA	1.83	4.45	3.06	2.75	2.25
Total Debt / (EBITDA - Capex)	-	-0.02	-0.49	-0.36	-0.34
Net Debt / (EBITDA - Capex)	1.69	4.22	2.82	2.63	2.21
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	505.77	174.98
Gross Profit, 1 Yr. Growth %	-	-	87.9	35.14	-0.68
EBITDA, 1 Yr. Growth %	190.33	117.64	90.44	33.64	1.95
EBITA, 1 Yr. Growth %	197.81	114.31	90.3	34.67	2.48
EBIT, 1 Yr. Growth %	197.81	114.31	90.3	34.67	2.48
Earnings From Cont. Operations, 1 Yr. Growth %	136.85	163.25	30.81	27.12	-0.68
Net Income, 1 Yr. Growth %	136.85	163.25	30.81	27.12	-0.68
Normalized Net Income, 1 Yr. Growth %	136.85	163.25	30.77	26.99	-0.72
Diluted EPS Before Extra, 1 Yr. Growth %	34.43	-77.96	-34.93	7.01	-24.77
Accounts Receivable, 1 Yr. Growth %	-	-	-	482.71	-44.8
Net Property, Plant and Equip., 1 Yr. Growth %	68.96	127.48	1.12K	-2.58	-10.27
Total Assets, 1 Yr. Growth %	262.23	389.87	76.82	10.82	-13.99
Tangible Book Value, 1 Yr. Growth %	226.85	-659.16	54.17	8.82	-17.7
Common Equity, 1 Yr. Growth %	226.85	-659.16	54.17	8.82	-17.7
Cash From Operations, 1 Yr. Growth %	373.86	120.84	57.08	22.25	5.44
Capital Expenditures, 1 Yr. Growth %	84.38	27.31	203.56	-29.84	-59.75
Levered Free Cash Flow, 1 Yr. Growth %	-	72.73	113.15	22.37	-13.37
Unlevered Free Cash Flow, 1 Yr. Growth %	-	72.73	113.15	22.37	-13.37
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-	308.13
Gross Profit, 2 Yr. CAGR %	-	-	90.35	59.35	15.86
EBITDA, 2 Yr. CAGR %	-	151.37	103.59	59.53	16.72
EBITA, 2 Yr. CAGR %	-	152.63	101.95	60.08	17.48
EBIT, 2 Yr. CAGR %	-	152.63	101.95	60.08	17.48
Earnings From Cont. Operations, 2 Yr. CAGR %	-	149.7	85.57	28.95	12.36
Net Income, 2 Yr. CAGR %	-	149.7	85.57	28.95	12.36
Normalized Net Income, 2 Yr. CAGR %	-	149.7	85.54	28.86	12.28
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-45.56	-62.13	-16.56	-10.27
Accounts Receivable, 2 Yr. CAGR %	-	-	-	-	79.34
Net Property, Plant and Equip., 2 Yr. CAGR %	-	96.05	427.02	244.88	-6.51
Total Assets, 2 Yr. CAGR %	-	321.25	194.31	39.98	-2.37
Tangible Book Value, 2 Yr. CAGR %	-	327.51	193.61	29.52	-5.37
Common Equity, 2 Yr. CAGR %	-	327.51	193.61	29.52	-5.37
Cash From Operations, 2 Yr. CAGR %	-	223.5	86.25	38.57	13.54
Capital Expenditures, 2 Yr. CAGR %	-	53.21	96.58	45.93	-46.86
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	91.88	61.5	2.96
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	91.88	61.5	2.96
Compound Annual Growth Rate Over Three Years
Gross Profit, 3 Yr. CAGR %	-	-	-	69.81	36.12
EBITDA, 3 Yr. CAGR %	-	-	129.15	76.93	37.41
EBITA, 3 Yr. CAGR %	-	-	129.86	76.43	37.97
EBIT, 3 Yr. CAGR %	-	-	129.86	76.43	37.97
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	101.29	63.58	18.2
Net Income, 3 Yr. CAGR %	-	-	101.29	63.58	18.2
Normalized Net Income, 3 Yr. CAGR %	-	-	101.27	63.51	18.14
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-42.23	-46.46	-19.39
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	260.7	200.22	120.17
Total Assets, 3 Yr. CAGR %	-	-	215.41	112.52	19
Tangible Book Value, 3 Yr. CAGR %	-	-	204.3	110.9	11.35
Common Equity, 3 Yr. CAGR %	-	-	204.3	110.9	11.35
Cash From Operations, 3 Yr. CAGR %	-	-	154.26	61.86	26.51
Capital Expenditures, 3 Yr. CAGR %	-	-	92.43	39.44	-5.01
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	65.16	31.22
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	65.16	31.22
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	-	74.96
EBITA, 5 Yr. CAGR %	-	-	-	-	75.74
EBIT, 5 Yr. CAGR %	-	-	-	-	75.74
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	59.42
Net Income, 5 Yr. CAGR %	-	-	-	-	59.42
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	59.36
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-31.1
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	110.18
Total Assets, 5 Yr. CAGR %	-	-	-	-	97.31
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	90.72
Common Equity, 5 Yr. CAGR %	-	-	-	-	90.72
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	84.17
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	15.01